+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report by Product (Ventricular Assist Devices, Counter Pulsation Devices, Pacemakers), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 105 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5921014
Description Jump to:
The global congestive heart failure treatment devices market size is expected to reach USD 46.58 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2022, which was followed by the pacemaker’s segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America dominated the overall market in terms of revenue share at over 40.55% in 2022; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. CHF Treatment Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. CHF Treatment Devices Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. CHF Treatment Devices Market: Product Estimates & Trend Analysis
4.1. CHF Treatment Devices Market: Key Takeaways
4.2. CHF Treatment Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Ventricular Assist Devices (VADs)
4.3.1. Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Counter Pulsation Devices
4.4.1. Counter pulsation devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Implantable Cardioverter Defibrillators
4.5.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Pacemakers
4.6.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Cardiac Resynchronization Therapy
4.7.1. Cardiac resynchronization therapy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. CHF Treatment Devices Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. CHF Treatment Devices Market by Region: Key Marketplace Takeaways
5.3. North America
5.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.6. Sweden
5.4.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.7. Norway
5.4.7.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.4.8. Denmark
5.4.8.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5. Asia-Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7. MEA
5.7.1. Saudi Arabia
5.7.1.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7.2. South Africa
5.7.2.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018-2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Jarvik Heart Inc.
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. ReliantHeart, Inc.
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Biotronik SE & Co. KG
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Berlin Heart GmbH
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Abbott (St. Jude Medical)
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Medtronic
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Boston Scientific Corporation
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Teleflex, Inc.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 3 North America CHF treatment devices market, by region, 2018-2030 (USD Million)
Table 4 U.S. CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 5 Canada CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 6 Europe CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 7 Europe CHF treatment devices market, by region, 2018-2030 (USD Million)
Table 8 Germany CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 9 UK CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 10 France CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 11 Italy CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 12 Spain CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 13 Sweden CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 14 Norway CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 15 Denmark CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 16 Asia-Pacific CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 17 Asia-Pacific CHF treatment devices market, by region, 2018-2030 (USD Million)
Table 18 China CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 19 Japan CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 20 India CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 21 Australia CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 22 Thailand CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 23 South Korea CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 24 Latin America CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 25 Latin America CHF treatment devices market, by region, 2018-2030 (USD Million)
Table 26 Brazil CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 27 Mexico CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 28 Argentina CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 29 Middle East and Africa CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 30 Middle East and Africa CHF treatment devices market, by region, 2018-2030 (USD Million)
Table 31 South Africa CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 32 Saudi Arabia CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 33 UAE CHF treatment devices market, by product, 2018-2030 (USD Million)
Table 34 Kuwait CHF treatment devices market, by product, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 CHF treatment devices: market outlook
Figure 9 CHF treatment devices competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 CHF treatment devices market driver impact
Figure 15 CHF treatment devices market restraint impact
Figure 16 CHF treatment devices market strategic initiatives analysis
Figure 17 CHF treatment devices market: Product movement analysis
Figure 18 CHF treatment devices market: Product outlook and key takeaways
Figure 19 Ventricular Assist Devices (VADs) market estimates and forecasts, 2018-2030 (USD Million)
Figure 20 LVAD market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 RVAD market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 BiVAD market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Counter Pulsation Devices market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Implantable Cardioverter Defibrillators market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Transvenous ICD market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Subcutaneous ICD market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Pacemakers market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Implantable pacemakers market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 External pacemakers market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Cardiac Resynchronization therapy market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Cardiac Resynchronization Therapy-Defibrillators (CRT-D) market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Global CHF treatment devices market: Regional movement analysis
Figure 34 Global CHF treatment devices market: Regional outlook and key takeaways
Figure 35 North America market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Canada market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Europe market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 UK market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Germany market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 France market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Italy market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Spain market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Norway market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Asia-Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Figure 48 China market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Japan market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 India market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Australia market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 UAE market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Jarvik Heart Inc.
  • ReliantHeart, Inc.
  • Biotronik SE & Co. KG
  • Berlin Heart GmbH
  • Abbott (St. Jude Medical)
  • Medtronic
  • Boston Scientific Corporation
  • Teleflex, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages105
PublishedDecember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 26.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 46.58 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Global Congestive Heart Failure Treatment Device Market by Product (Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker), End-User (Ambulatory Surgery Center, Hospitals & Clinics) - Forecast 2024-2030 - Product Image

Global Congestive Heart Failure Treatment Device Market by Product (Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker), End-User (Ambulatory Surgery Center, Hospitals & Clinics) - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Congestive Heart Failure (CHF) Treatment Devices - Global Strategic Business Report - Product Image

Congestive Heart Failure (CHF) Treatment Devices - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Heart Pump Device Market Size, Share & Trends Analysis Report By Type, By Product (Ventricular Assist Devices, Total Artificial Hearts), By End-use (Hospital, Cardiac Centers), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Heart Pump Device Market Size, Share & Trends Analysis Report By Type, By Product (Ventricular Assist Devices, Total Artificial Hearts), By End-use (Hospital, Cardiac Centers), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 120 Pages
  • Global
From
Global Ventricular Assist Devices Market Report by Product, Flow Type, Product Type, Application, End User, and Region 2024-2032 - Product Image

Global Ventricular Assist Devices Market Report by Product, Flow Type, Product Type, Application, End User, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.